Finding what matters
The U.S. Preventive Services Task Force is a group of scientists and physicians given the formidable responsibility of sorting through the wide array of tests available for major diseases and deciding which should be part of the national standard of care. These are weighty decisions, because in the world’s most expensive health system insurers are required to pay for those tests the group deems beneficial.1 Fine-tuning when to recommend diagnostic screenings is especially fraught, as getting these decisions wrong leads to unnecessary, costly, and painful medical interventions. Conversely getting them right can help catch disease earlier when treatment is more effective, giving patients greater quality of life.
This group’s decisions often hinge on what is known as clinical significance: if knowing something makes zero difference for a therapeutic approach or is as likely to cause harm as benefit, then it is not worth investing resources to get that data. For instance DNA tests can fall into this category, as the impact of certain genes is currently unknown. For those possessing some unusual variant, finding that out would engender agita but not much else. Read more…
- When it comes to cost it’s not even close, with the U.S. spending over $10,000 per person on healthcare, about 18% of GDP, with runner-up Switzerland around $8,000 and a steep dropoff in the numbers after that. ↩
- And/or potentially undermining society and the fabric of democracy, depending on your point of view. Also the term unicorn technically only applies to non-public companies but we’ll relax the definition. ↩
- In the process drastically weakening the positions of real estate agents and brokers, which was a bonus or drawback depending on which side of the table you sat on. ↩
- Yes that’s the actual term, and it pretty much means what you expect. Who knew doctors were so whimsical? ↩